Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration
Metastatic Prostate Adenocarcinoma
DRUG: Local chemotherapy
Number of alive patient, 3 years
Number of alive patient disease free, 3 years
Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration